| Catalent is a holding company. Through its subsidiaries, Co. provides development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products. Co.'s segments include: Biologics, which provides biologic cell-line, cell therapy and viral-based gene therapy development and manufacturing; Softgel and Oral Technologies, which provides formulation, development, and manufacturing services for soft capsules, and manufactures oral solid dose forms; and Clinical Supply Services, which provides manufacturing, packaging, storage, distribution, and inventory management for drugs and protein and cell and gene therapy biologics in clinical trials. We show 33 historical shares outstanding datapoints in our coverage of CTLT's shares outstanding history.|
Understanding the changing numbers of CTLT shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like CTLT versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching CTLT by allowing them to research CTLT shares outstanding history
as well as any other stock in our coverage universe.